Ehrenreich, LifeSciences NY Annual Conference

Articles

March 14, 2022

Honen, Viewpoint, Analyzing a Startup’s Potential

March 18, 2020

COVID-19: Legal Considerations for Maintaining Business Continuity

Articles

November 19, 2024

Navigating Decentralized Clinical Trials With FDA’s Guidance

Client Alerts-Psychedelics and Mental Health Therapeutics

October 29, 2024

Insights for Psychedelic Stakeholders From Recent FDA Public Meeting on Advancing Treatments for PTSD

Articles

October 1, 2024

Health Insurers – Making Consumers Wait for Weight-Loss Drugs

Client Alerts-Psychedelics and Mental Health Therapeutics Client Alerts-Health Care and Life Sciences

September 10, 2024

FDA Denies Approval of New Drug Application for MDMA and Requests Additional Study

Articles

August 8, 2024

What’s Next for MDMA?

Articles

July 12, 2024

The FTC’s Non-Compete Ban: Anticipated Impacts on the Health Care Industry

Articles

July 8, 2024

AI Demystified: The Transformative Impact of AI in Health Care

Articles

April 12, 2024

Next-Gen Medical Devices: Evolving with AI to Ensure Safety and Efficacy

Articles

March 25, 2024

Second Circuit Baby Food Ruling Disregards FDA’s Expertise

Client Alerts-Psychedelics and Mental Health Therapeutics

March 21, 2024

FDA Breakthrough Therapy Designation for LSD Formulation

Articles

January 29, 2024

Major Milestone for Psychedelic-Assisted Therapy

Articles

January 19, 2024

The Direct Primary Care Model: Considerations for NY Providers, Patients and Employers

Client Alerts-Psychedelics and Mental Health Therapeutics

January 3, 2024

Progress for Research Funding on Psychedelics for Military Personnel and Veterans/First Responders

Client Alerts-Psychedelics and Mental Health Therapeutics

December 21, 2023

New Drug Application is a Major Milestone for Psychedelic-Assisted Therapy

Client Alerts-Psychedelics and Mental Health Therapeutics

September 6, 2023

Psychedelic-Assisted Therapy – First Professional Practice Guidelines

Articles

July 1, 2023

FDA Draft Guidance on Clinical Trials for Psychedelics

Articles

January 29, 2023

Transitioning for FDA EUA Expiration

Articles

September 22, 2022

APA Issues Position Statement on Psychedelics Use

Articles

September 15, 2022

Kraus, Glasgow, The Limitations of Judicial Discretion

Articles

August 19, 2022

BIPOC Underrepresented in Ketamine Clinical Trials

Articles

August 18, 2022

Markov, Improving Diversity In Psychedelics Research

Articles

August 10, 2022

FDA Issues Draft Guidance on Diversity and Inclusion in Clinical Trials

Articles

May 10, 2022

PREP Act: Limitations of Immunity and Fed Court Jurisdiction

Articles

March 4, 2022

How the Pandemic Brought Science to the Forefront of Public Consciousness

Articles

February 18, 2022

Cannabis Regulations, Marijuana Regulation and Taxation Act (MRTA)

Articles

January 25, 2022

Kraus, Glasgow, Duty To Warn and the Learned Intermediary Doctrine

Articles

January 21, 2022

Hujer, The State of Cannabis in New York

Articles

December 21, 2021

Smith, Kraus, Limit Legal Risks, Medical Device Regulations

Client Alerts-Health Care and Life Sciences

December 1, 2021

Repeal of Final Medicare Coverage Rule

Client Alerts-Cannabis

October 20, 2021

Cannabis Growers Currently Unprotected by New York State’s Seed Law

Client Alerts-Cannabis

September 3, 2021

Key Appointments to Office of Cannabis Mgmt, Cannabis Control Board

Articles

July 22, 2021

Kraus, Regulatory Risk Assessment vs. Tort Law Causation

Client Alerts-Cannabis

July 15, 2021

Cannabis Entrepreneurs Should Plan Banking Strategy Now

Client Alerts-Cannabis

June 30, 2021

Marijuana Regulation and Taxation Act – Part 1: Licensing Guidelines

Articles

June 15, 2021

Hurdles in Baby Food Contamination Class Action

Articles

May 26, 2021

Kraus, Schmidt, PREP Act Immunity, Shareholder Derivative Litigation

Articles

May 21, 2021

Mulvehill, Pincelli, Legalized Recreational Marijuana in New York

Client Alerts-Labor and Employment Client Alerts-Cannabis

April 1, 2021

Legalized Recreational Marijuana Use Comes to the NYS Workplace

Client Alerts-Cannabis

April 1, 2021

New York State Legalizes Marijuana for Adult Use

Articles

March 26, 2021

Kraus, Smith, Lessons From the COVID-19 Pandemic

Articles

February 19, 2021

Hujer, Cannabis Update: Hemp Applications Take Shape

Articles

January 15, 2021

Hujer, Planning for NYS 2021 Hemp Regulations

Articles

December 7, 2020

Kraus, COVID-19 Vaccines, Litigation Opportunities Unlikely

Articles

June 17, 2020

Glasgow, MDL Courts, Rule 702 Reform

Articles

March 13, 2020

NYS Seed Law Protects Hemp Growers

Articles

January 2, 2020

Hujer, Key Lessons For Hemp Companies

LifeSciences NY Annual Conference – Together ’24: Elliott Ehrenreich

Spotlight on Success: “Building an Investor-Ready Life Sciences Startup”

Related Insights

Want to Know More?